tiprankstipranks
Impact BioMedical, Inc. (IBO)
:IBO
US Market

Impact BioMedical, Inc. (IBO) Financial Statements

Compare
107 Followers

Impact BioMedical, Inc. Financial Overview

Impact BioMedical, Inc.'s market cap is currently ―. The company's EPS TTM is $-2.159; its P/E ratio is -1.35; Impact BioMedical, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueC$ 32.00KC$ 2.33MC$ 0.00C$ 50.00KC$ 50.00K
Gross ProfitC$ -1.54MC$ 2.33MC$ 0.00C$ 50.00KC$ 50.00K
Operating IncomeC$ -4.27MC$ 551.66KC$ -4.03MC$ -3.40MC$ -3.40M
EBITDAC$ -3.13MC$ -1.54MC$ -2.84MC$ -6.30MC$ -6.30M
Net IncomeC$ -11.84MC$ -2.05MC$ -4.34MC$ -7.05MC$ -7.05M
Balance Sheet
Cash & Short-Term InvestmentsC$ 3.00KC$ 2.00MC$ 1.00KC$ 2.00KC$ 46.00K
Total AssetsC$ 17.41MC$ 20.29MC$ 44.63MC$ 46.50MC$ 56.42M
Total DebtC$ 0.00C$ 8.88MC$ 12.07MC$ 9.99MC$ 12.52M
Net DebtC$ -3.00KC$ 6.88MC$ 12.07MC$ 9.99MC$ 12.48M
Total LiabilitiesC$ 1.85MC$ 13.05MC$ 16.37MC$ 13.83MC$ 16.50M
Stockholders' EquityC$ 12.61MC$ 4.26MC$ 25.22MC$ 29.56MC$ 36.61M
Cash Flow
Free Cash FlowC$ -1.89MC$ -5.64MC$ -2.87MC$ -4.43MC$ -3.25M
Operating Cash FlowC$ -1.89MC$ -5.64MC$ -2.85MC$ -4.33MC$ -3.25M
Investing Cash FlowC$ 3.00KC$ 2.88KC$ -15.00KC$ -2.09MC$ -42.93K
Financing Cash FlowC$ -109.00KC$ 8.51MC$ 2.87MC$ 7.01MC$ 3.38M
Currency in CAD

Impact BioMedical, Inc. Earnings and Revenue History

Impact BioMedical, Inc. Debt to Assets

Impact BioMedical, Inc. Cash Flow

Impact BioMedical, Inc. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.